retatrutide clinical trial results 2025 New Phase 3 data just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving historically associated with bariatric surgery. A few important caveats Looking forward to when #retatrutide's

Nutrient combinations sensed by L-cell receptors potentiate GLP-1 secretion

This rigorous analysis examined 17 studies on temperature effects on insulin, finding that unopened vials maintained potency for up to six months at temperatures up to 25C (77F) and up to two months at 37C (98.6F)

Ozempic rose from a 10 th place ranking among the 10 top-selling Part D drugs in 2021, with gross spending of $2.6 billion, to 6 th place in 2022, with spending of $4.6 billion (Figure 2)

At House of Aesthetix, our reach extends beyond our San Diego clinic to serve clients from many of the regions most vibrant and beautiful communities

doi: 10.1016/j.bbrc.2019.01.103 151 LiYDuffyKBOttingerMARayBBaileyJAHollowayHWet al

SELECT trial demonstrated 20% MACE reduction in 17,604 patients -- the first anti-obesity drug with proven cardiovascular benefit